To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Athryium-backed Biom’up adds two to C-suite
Biom'up, a developer of hemostatic products, has named Stéphanie Boileau-Canu as chief financial officer and Emmanuel Zylber as chief scientific officer.
